392 related articles for article (PubMed ID: 33568263)
1. Emerging mechanisms and applications of ferroptosis in the treatment of resistant cancers.
Li B; Yang L; Peng X; Fan Q; Wei S; Yang S; Li X; Jin H; Wu B; Huang M; Tang S; Liu J; Li H
Biomed Pharmacother; 2020 Oct; 130():110710. PubMed ID: 33568263
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
3. Targeting Ferroptosis to Iron Out Cancer.
Hassannia B; Vandenabeele P; Vanden Berghe T
Cancer Cell; 2019 Jun; 35(6):830-849. PubMed ID: 31105042
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms of ferroptosis and its role in cancer therapy.
Xu T; Ding W; Ji X; Ao X; Liu Y; Yu W; Wang J
J Cell Mol Med; 2019 Aug; 23(8):4900-4912. PubMed ID: 31232522
[TBL] [Abstract][Full Text] [Related]
6. NR5A2 synergizes with NCOA3 to induce breast cancer resistance to BET inhibitor by upregulating NRF2 to attenuate ferroptosis.
Qiao J; Chen Y; Mi Y; Jin H; Huang T; Liu L; Gong L; Wang L; Wang Q; Zou Z
Biochem Biophys Res Commun; 2020 Sep; 530(2):402-409. PubMed ID: 32536370
[TBL] [Abstract][Full Text] [Related]
7. Ferroptosis: An emerging approach for targeting cancer stem cells and drug resistance.
Elgendy SM; Alyammahi SK; Alhamad DW; Abdin SM; Omar HA
Crit Rev Oncol Hematol; 2020 Nov; 155():103095. PubMed ID: 32927333
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs.
Su Y; Zhao B; Zhou L; Zhang Z; Shen Y; Lv H; AlQudsy LHH; Shang P
Cancer Lett; 2020 Jul; 483():127-136. PubMed ID: 32067993
[TBL] [Abstract][Full Text] [Related]
9. Recent Progress in Ferroptosis Inducers for Cancer Therapy.
Liang C; Zhang X; Yang M; Dong X
Adv Mater; 2019 Dec; 31(51):e1904197. PubMed ID: 31595562
[TBL] [Abstract][Full Text] [Related]
10. Targeting Regulated Cell Death with Pharmacological Small Molecules: An Update on Autophagy-Dependent Cell Death, Ferroptosis, and Necroptosis in Cancer.
Wu J; Ye J; Xie Q; Liu B; Liu M
J Med Chem; 2022 Feb; 65(4):2989-3001. PubMed ID: 35130435
[TBL] [Abstract][Full Text] [Related]
11. Recent progress on targeting ferroptosis for cancer therapy.
Xu G; Wang H; Li X; Huang R; Luo L
Biochem Pharmacol; 2021 Aug; 190():114584. PubMed ID: 33915157
[TBL] [Abstract][Full Text] [Related]
12. Directly targeting glutathione peroxidase 4 may be more effective than disrupting glutathione on ferroptosis-based cancer therapy.
Wei Y; Lv H; Shaikh AB; Han W; Hou H; Zhang Z; Wang S; Shang P
Biochim Biophys Acta Gen Subj; 2020 Apr; 1864(4):129539. PubMed ID: 31958545
[TBL] [Abstract][Full Text] [Related]
13. Fighting Resilient Cancers with Iron.
Chen JJ; Galluzzi L
Trends Cell Biol; 2018 Feb; 28(2):77-78. PubMed ID: 29223642
[TBL] [Abstract][Full Text] [Related]
14. Overcoming cancer chemotherapy resistance by the induction of ferroptosis.
Wang Y; Wu X; Ren Z; Li Y; Zou W; Chen J; Wang H
Drug Resist Updat; 2023 Jan; 66():100916. PubMed ID: 36610291
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor propellant glutathione peroxidase 4 induces ferroptosis in cancer cells and enhances anticancer effect of cisplatin.
Zhang X; Sui S; Wang L; Li H; Zhang L; Xu S; Zheng X
J Cell Physiol; 2020 Apr; 235(4):3425-3437. PubMed ID: 31556117
[TBL] [Abstract][Full Text] [Related]
16. Triggered ferroptotic polymer micelles for reversing multidrug resistance to chemotherapy.
Gao M; Deng J; Liu F; Fan A; Wang Y; Wu H; Ding D; Kong D; Wang Z; Peer D; Zhao Y
Biomaterials; 2019 Dec; 223():119486. PubMed ID: 31520887
[TBL] [Abstract][Full Text] [Related]
17. The induction of ferroptosis by impairing STAT3/Nrf2/GPx4 signaling enhances the sensitivity of osteosarcoma cells to cisplatin.
Liu Q; Wang K
Cell Biol Int; 2019 Nov; 43(11):1245-1256. PubMed ID: 30811078
[TBL] [Abstract][Full Text] [Related]
18. Targeting ferroptosis in ovarian cancer: Novel strategies to overcome chemotherapy resistance.
Kapper C; Oppelt P; Arbeithuber B; Gyunesh AA; Vilusic I; Stelzl P; Rezk-Füreder M
Life Sci; 2024 Jul; 349():122720. PubMed ID: 38762066
[TBL] [Abstract][Full Text] [Related]
19. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
20. Functional role of ferroptosis on cancers, activation and deactivation by various therapeutic candidates-an update.
Nguyen THP; Mahalakshmi B; Velmurugan BK
Chem Biol Interact; 2020 Feb; 317():108930. PubMed ID: 31866335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
